|
US20110064811A1
(en)
|
2005-12-28 |
2011-03-17 |
Patricia Hurter |
Solid forms of N-[2,4-BIS(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
|
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
|
KR101660050B1
(ko)
|
2008-01-04 |
2016-09-26 |
인텔리카인, 엘엘씨 |
특정 화학 물질, 조성물 및 방법
|
|
MX2011013816A
(es)
|
2009-06-29 |
2012-04-11 |
Incyte Corp |
Pirimidinonas como inhibidores de pi3k.
|
|
US8759359B2
(en)
|
2009-12-18 |
2014-06-24 |
Incyte Corporation |
Substituted heteroaryl fused derivatives as PI3K inhibitors
|
|
WO2011123609A1
(en)
*
|
2010-03-31 |
2011-10-06 |
Glaxo Group Limited |
Imidazolyl-imidazoles as kinase inhibitors
|
|
EP2558463A1
(en)
|
2010-04-14 |
2013-02-20 |
Incyte Corporation |
Fused derivatives as i3 inhibitors
|
|
WO2011163195A1
(en)
|
2010-06-21 |
2011-12-29 |
Incyte Corporation |
Fused pyrrole derivatives as pi3k inhibitors
|
|
CA2818903C
(en)
*
|
2010-12-14 |
2021-03-23 |
Electrophoretics Limited |
5-(1,3-benzoxazol-2-yl)-4-(pyridin-4-yl)pyrimidin-2-amine and its use as a casein kinase 1delta inhibitor
|
|
ES2764848T3
(es)
|
2010-12-20 |
2020-06-04 |
Incyte Holdings Corp |
N-(1-(fenilo sustituido)etilo)-9H-purina-6-aminas como inhibidores de PI3K
|
|
US8754114B2
(en)
|
2010-12-22 |
2014-06-17 |
Incyte Corporation |
Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
|
|
EP3238722B1
(en)
|
2011-01-10 |
2019-03-13 |
Infinity Pharmaceuticals, Inc. |
Solid forms of isoquinolinones
|
|
US9108984B2
(en)
|
2011-03-14 |
2015-08-18 |
Incyte Corporation |
Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors
|
|
GB201104267D0
(en)
|
2011-03-14 |
2011-04-27 |
Cancer Rec Tech Ltd |
Pyrrolopyridineamino derivatives
|
|
US9126948B2
(en)
|
2011-03-25 |
2015-09-08 |
Incyte Holdings Corporation |
Pyrimidine-4,6-diamine derivatives as PI3K inhibitors
|
|
AR087701A1
(es)
|
2011-08-31 |
2014-04-09 |
Japan Tobacco Inc |
Derivados de pirazol con actividad inhibidora de sglt1
|
|
KR20230038593A
(ko)
|
2011-09-02 |
2023-03-20 |
인사이트 홀딩스 코포레이션 |
Ｐｉ３ｋ 억제제로서 헤테로시클릴아민
|
|
AU2012321815B2
(en)
|
2011-10-07 |
2017-03-09 |
Takeda Pharmaceutical Company Limited |
1 - arylcarbonyl - 4 - oxy - piperidine compounds useful for the treatment of neurodegenerative diseases
|
|
CA2851589C
(en)
|
2011-10-18 |
2019-02-19 |
Astellas Pharma Inc. |
Bicyclic heterocyclic compound
|
|
AR090037A1
(es)
|
2011-11-15 |
2014-10-15 |
Xention Ltd |
Derivados de tieno y/o furo-pirimidinas y piridinas inhibidores de los canales de potasio
|
|
CA2856839C
(en)
|
2011-12-01 |
2019-07-30 |
Chemocentryx, Inc. |
Substituted anilines as ccr(4) antagonists
|
|
AR090548A1
(es)
|
2012-04-02 |
2014-11-19 |
Incyte Corp |
Azaheterociclobencilaminas biciclicas como inhibidores de pi3k
|
|
EP3176170B1
(en)
|
2012-06-13 |
2018-11-14 |
Incyte Holdings Corporation |
Substituted tricyclic compounds as fgfr inhibitors
|
|
WO2013186159A1
(en)
|
2012-06-13 |
2013-12-19 |
F. Hoffmann-La Roche Ag |
New diazaspirocycloalkane and azaspirocycloalkane
|
|
US8828998B2
(en)
|
2012-06-25 |
2014-09-09 |
Infinity Pharmaceuticals, Inc. |
Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors
|
|
WO2014007228A1
(ja)
|
2012-07-03 |
2014-01-09 |
小野薬品工業株式会社 |
ソマトスタチン受容体作動活性を有する化合物およびその医薬用途
|
|
WO2014009891A1
(en)
*
|
2012-07-11 |
2014-01-16 |
Piramal Enterprises Limited |
Heterocyclic compounds for use in the treatment of cancers
|
|
US9388185B2
(en)
|
2012-08-10 |
2016-07-12 |
Incyte Holdings Corporation |
Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
|
|
CN113679717A
(zh)
|
2012-08-22 |
2021-11-23 |
康奈尔大学 |
用于抑制肌成束蛋白的方法
|
|
CA2883221C
(en)
*
|
2012-08-24 |
2020-01-21 |
Treventis Corporation |
Benzofurazan anti-amyloid compounds and methods
|
|
CN102850341B
(zh)
*
|
2012-09-05 |
2015-02-18 |
浙江工业大学 |
一种噻二唑类化合物及其制备与应用
|
|
GB201216018D0
(en)
|
2012-09-07 |
2012-10-24 |
Cancer Rec Tech Ltd |
Pharmacologically active compounds
|
|
HRP20191937T1
(hr)
|
2012-09-25 |
2020-01-10 |
F. Hoffmann - La Roche Ag |
Derivati heksahidropirolo [3,4-c]pirola i srodni spojevi kao inhibitori autotaksina (atx) i kao inhibitori proizvodnje lizofosfatidne kiseline (lpa) za liječenje npr. bubrežnih bolesti
|
|
CN103739594A
(zh)
*
|
2012-10-17 |
2014-04-23 |
南京大学 |
一类含吡嗪环和三氮唑结构的席夫碱类衍生物及其制法
|
|
NZ708563A
(en)
|
2012-11-01 |
2019-02-22 |
Infinity Pharmaceuticals Inc |
Treatment of cancers using pi3 kinase isoform modulators
|
|
PE20151412A1
(es)
|
2012-11-27 |
2015-10-10 |
Thomas Helledays Stiftelse For Medicinsk Forskning |
Derivados de pirimidin-2,4-diamina para el tratamiento de cancer
|
|
US9266892B2
(en)
|
2012-12-19 |
2016-02-23 |
Incyte Holdings Corporation |
Fused pyrazoles as FGFR inhibitors
|
|
WO2014103801A1
(ja)
|
2012-12-28 |
2014-07-03 |
株式会社新日本科学 |
イミダゾピリジン誘導体を有効成分として含むｏｃｔ３活性阻害剤又はｏｃｔ３検出剤
|
|
EP2953950B1
(en)
*
|
2013-02-11 |
2021-01-13 |
The Regents of The University of California |
Compositions and methods for treating neurodegenerative diseases
|
|
AR095079A1
(es)
|
2013-03-12 |
2015-09-16 |
Hoffmann La Roche |
Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo
|
|
CN105338812A
(zh)
|
2013-03-15 |
2016-02-17 |
怀特黑德生物医学研究院 |
苯并咪唑衍生物及其用途
|
|
US9776996B2
(en)
|
2013-03-15 |
2017-10-03 |
Epizyme, Inc. |
Substituted 6,5-fused bicyclic heteroaryl compounds
|
|
US9045477B2
(en)
|
2013-03-15 |
2015-06-02 |
Epizyme, Inc. |
Substituted 6,5-fused bicyclic heteroaryl compounds
|
|
SG10201708520YA
(en)
|
2013-04-19 |
2017-12-28 |
Incyte Corp |
Bicyclic heterocycles as fgfr inhibitors
|
|
US9797882B2
(en)
|
2013-07-09 |
2017-10-24 |
The Translational Genomics Research Institute |
Method of screening for a compound for inhibitory activity of FN14-tweak interaction
|
|
US9238034B2
(en)
*
|
2013-07-09 |
2016-01-19 |
The Translational Genomics Research Institute |
FN14 antagonists and therapeutic uses thereof
|
|
TWI649308B
(zh)
|
2013-07-24 |
2019-02-01 |
小野藥品工業股份有限公司 |
喹啉衍生物
|
|
GB201314452D0
(en)
|
2013-08-13 |
2013-09-25 |
Ostara Biomedical Ltd |
Embryo implantation
|
|
RU2570907C2
(ru)
*
|
2013-10-21 |
2015-12-20 |
Автономная Некоммерческая Организация "Научно-Исследовательский Центр Биотехнологии Антибиотиков И Других Биологически Активных Веществ "Биоан" |
Производные 3-ациламинопиридин-2(1h)-она, применимые как ингибиторы серин-треониновой протеинкиназы gsk3b в качестве лекарственных препаратов для лечения диабета ii типа.
|
|
BR112016011727A2
(pt)
|
2013-11-22 |
2017-08-08 |
CL BioSciences LLC |
Antagonistas de gastrina para o tratamento e prevenção de osteoporose
|
|
RS56776B1
(sr)
|
2013-11-26 |
2018-04-30 |
Hoffmann La Roche |
Derivati oktahidro-ciklobuta [1,2-c;3,4-c']dipirola kao inhibitori autotaksina
|
|
GB201321738D0
(en)
*
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic Agents
|
|
US10087151B2
(en)
|
2014-01-09 |
2018-10-02 |
The J. David Gladstone Institutes, A Testimentary Trust Established Under The Will Of J. David Gladstone |
Substituted benzoxazine and related compounds
|
|
US9815841B2
(en)
|
2014-01-29 |
2017-11-14 |
Glaxosmithkline Intellectual Property Development Limited |
Compounds
|
|
CN105940004B
(zh)
|
2014-01-29 |
2018-02-02 |
葛兰素史密斯克莱知识产权发展有限公司 |
化合物
|
|
US10167286B2
(en)
|
2014-02-11 |
2019-01-01 |
Mitokinin, Inc. |
Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease
|
|
TW201613860A
(en)
|
2014-02-13 |
2016-04-16 |
Incyte Corp |
Cyclopropylamines as LSD1 inhibitors
|
|
TWI720451B
(zh)
|
2014-02-13 |
2021-03-01 |
美商英塞特控股公司 |
作為lsd1抑制劑之環丙胺
|
|
US9527835B2
(en)
|
2014-02-13 |
2016-12-27 |
Incyte Corporation |
Cyclopropylamines as LSD1 inhibitors
|
|
DK3105218T3
(da)
|
2014-02-13 |
2019-11-04 |
Incyte Corp |
Cyclopropylaminer som lsd1-inhibitorer
|
|
CN106232583B
(zh)
|
2014-02-20 |
2020-04-24 |
康奈尔大学 |
用于抑制肌成束蛋白的化合物和方法
|
|
PL3110812T3
(pl)
|
2014-02-27 |
2019-10-31 |
Treventis Corp |
Związki antyamyloidowe zawierające benzofurazan
|
|
CA2935612A1
(en)
|
2014-03-26 |
2015-10-01 |
F. Hoffmann-La Roche Ag |
Condensed [1,4]diazepine compounds as autotaxin (atx) and lysophosphatidic acid (lpa) production inhibitors
|
|
UA118582C2
(uk)
|
2014-03-26 |
2019-02-11 |
Ф. Хоффманн-Ля Рош Аг |
Біциклічні сполуки як інгібітори продукції аутотаксину (atx) і лізофосфатидилової кислоти (lpa)
|
|
US20170029388A1
(en)
*
|
2014-04-11 |
2017-02-02 |
Intercontinental Great Brands Llc |
Treatment of Neurodegenerative Diseases with Asparagine Endopeptidase (AEP) Inhibitors and Compositions Related Thereto
|
|
US20150320755A1
(en)
|
2014-04-16 |
2015-11-12 |
Infinity Pharmaceuticals, Inc. |
Combination therapies
|
|
EP3134392B1
(en)
*
|
2014-04-19 |
2019-01-02 |
Sunshine Lake Pharma Co., Ltd. |
Sulfonamide derivatives and pharmaceutical applications thereof
|
|
EP3597649B8
(en)
*
|
2014-04-23 |
2022-02-16 |
Dart Neuroscience LLC |
Compositions containing substituted [1,2,4]triazolo[1,5-a]pyrimidin-7-yl compounds as pde2 inhibitors
|
|
WO2015170218A1
(en)
|
2014-05-07 |
2015-11-12 |
Pfizer Inc. |
Tropomyosin-related kinase inhibitors
|
|
CN104059060B
(zh)
*
|
2014-05-30 |
2017-08-01 |
西安交通大学 |
一种5‑(1h‑吲哚‑3‑亚甲基)‑1,3‑噻唑烷‑4‑酮类衍生物及其合成方法和应用
|
|
EP3151833A4
(en)
|
2014-06-04 |
2018-01-10 |
Thomas Helledays Stiftelse För Medicinsk Forskning |
Mth1 inhibitors for treatment of inflammatory and autoimmune conditions
|
|
CA2949785A1
(en)
|
2014-06-04 |
2015-12-10 |
Thomas Helledays Stiftelse For Medicinsk Forskning |
Mth1 inhibitors for treatment of cancer
|
|
US10077277B2
(en)
|
2014-06-11 |
2018-09-18 |
Incyte Corporation |
Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors
|
|
WO2016007736A1
(en)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Imidazopyrazines as lsd1 inhibitors
|
|
US9695168B2
(en)
|
2014-07-10 |
2017-07-04 |
Incyte Corporation |
Substituted imidazo[1,5-α]pyridines and imidazo[1,5-α]pyrazines as LSD1 inhibitors
|
|
WO2016007722A1
(en)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Triazolopyridines and triazolopyrazines as lsd1 inhibitors
|
|
WO2016007727A1
(en)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Triazolopyridines and triazolopyrazines as lsd1 inhibitors
|
|
RU2017105133A
(ru)
*
|
2014-07-31 |
2018-08-28 |
Мерк Патент Гмбх |
Индолизиновые производные, которые применяют при нейродегенеративных заболеваниях
|
|
US20170204089A1
(en)
|
2014-08-04 |
2017-07-20 |
Drexel University |
Novel compounds and methods of treating or ameliorating an il-1r-mediated disease or disorder using same
|
|
JO3589B1
(ar)
|
2014-08-06 |
2020-07-05 |
Novartis Ag |
مثبطات كيناز البروتين c وطرق استخداماتها
|
|
AU2015330923B2
(en)
|
2014-10-07 |
2020-03-12 |
Vertex Pharmaceuticals Incorporated |
Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator
|
|
US10851105B2
(en)
|
2014-10-22 |
2020-12-01 |
Incyte Corporation |
Bicyclic heterocycles as FGFR4 inhibitors
|
|
GB201419579D0
(en)
*
|
2014-11-03 |
2014-12-17 |
Iomet Pharma Ltd |
Pharmaceutical compound
|
|
TWI568737B
(zh)
|
2014-11-05 |
2017-02-01 |
達特神經科學（開曼）有限責任公司 |
作為ｐｄｅ２抑制劑之經取代的５－甲基－［１，２，４］三唑并［１，５－ａ］嘧啶－２－胺化合物
|
|
US10208034B2
(en)
|
2014-12-25 |
2019-02-19 |
Ono Pharmaceutical Co., Ltd. |
Quinoline derivative
|
|
GB201501302D0
(en)
|
2015-01-27 |
2015-03-11 |
Ostara Biomedical Ltd |
Embryo implantation
|
|
MA41551A
(fr)
|
2015-02-20 |
2017-12-26 |
Incyte Corp |
Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
|
|
WO2016134294A1
(en)
|
2015-02-20 |
2016-08-25 |
Incyte Corporation |
Bicyclic heterocycles as fgfr4 inhibitors
|
|
MX373169B
(es)
|
2015-02-20 |
2020-04-24 |
Incyte Holdings Corp |
Heterociclos bicíclicos como inhibidores de receptores del factor de crecimiento fibroblástico (fgfr).
|
|
AU2016222556B2
(en)
|
2015-02-27 |
2020-08-27 |
Incyte Holdings Corporation |
Salts of Pl3K inhibitor and processes for their preparation
|
|
CN107847480B
(zh)
|
2015-03-23 |
2021-06-25 |
墨尔本大学 |
呼吸性疾病的治疗
|
|
PE20180455A1
(es)
|
2015-04-03 |
2018-03-05 |
Incyte Corp |
Compuestos heterociclicos como inhibidores de lsd1
|
|
MA41898A
(fr)
|
2015-04-10 |
2018-02-13 |
Hoffmann La Roche |
Dérivés de quinazolinone bicyclique
|
|
JP2018514572A
(ja)
*
|
2015-04-30 |
2018-06-07 |
エムユーエスシー ファウンデーション フォー リサーチ ディベロップメント |
オキシンドール化合物およびその医薬組成物
|
|
WO2016183063A1
(en)
|
2015-05-11 |
2016-11-17 |
Incyte Corporation |
Crystalline forms of a pi3k inhibitor
|
|
WO2016183060A1
(en)
|
2015-05-11 |
2016-11-17 |
Incyte Corporation |
Process for the synthesis of a phosphoinositide 3-kinase inhibitor
|
|
GB201508276D0
(en)
*
|
2015-05-14 |
2015-06-24 |
Electrophoretics Ltd |
A casein kinase 1 delta inhibitor
|
|
GB201509134D0
(en)
|
2015-05-28 |
2015-07-15 |
Electrophoretics Ltd |
Biomolecules involved in Alzheimer's disease
|
|
WO2016196644A1
(en)
*
|
2015-06-01 |
2016-12-08 |
Bantam Pharmaceutical, Llc |
Substituted pyrazole and pyrrole compounds and methods for using them for inhibition of initiation of translation and treatment of diseases and disorders relating thereto
|
|
WO2016202756A1
(en)
|
2015-06-18 |
2016-12-22 |
Bayer Pharma Aktiengesellschaft |
Substituted 2-(1h-pyrazol-1-yl)-1h-benzimidazole compounds
|
|
WO2016202758A1
(en)
|
2015-06-18 |
2016-12-22 |
Bayer Pharma Aktiengesellschaft |
Substituted 2-(1h-pyrazol-1-yl)-1h-benzimidazole compounds
|
|
WO2017000277A1
(en)
*
|
2015-07-01 |
2017-01-05 |
Merck Sharp & Dohme Corp. |
Substituted triazolo bicycliccompounds as pde2 inhibitors
|
|
JP2018525345A
(ja)
*
|
2015-07-01 |
2018-09-06 |
ノースウェスタン ユニバーシティ |
置換キナゾリン化合物及びグルコセレブロシダーゼ活性の調節のためのその使用
|
|
UA126277C2
(uk)
|
2015-08-12 |
2022-09-14 |
Інсайт Корпорейшн |
Солі інгібітору lsd1
|
|
CN105061462B
(zh)
*
|
2015-08-18 |
2017-05-24 |
沈阳药科大学 |
含有酰胺的四氢苯并[4,5]噻吩并[2,3‑d]嘧啶类化合物及其应用
|
|
CR20180058A
(es)
*
|
2015-09-04 |
2018-02-26 |
Hoffmann La Roche |
Nuevos derivados de fenoximetilo
|
|
RU2760373C2
(ru)
|
2015-09-18 |
2021-11-24 |
Какен Фармасьютикал Ко., Лтд. |
Биарильное производное и содержащее его лекарственное средство
|
|
BR112017026682A2
(pt)
|
2015-09-24 |
2018-08-14 |
Hoffmann La Roche |
novos compostos bicíclicos como inibidores de dupla ação de atx/ca
|
|
PE20180552A1
(es)
|
2015-09-24 |
2018-04-02 |
Hoffmann La Roche |
Nuevos compuestos biciclicos como inhibidores duales de atx/ca
|
|
EP3353176B1
(en)
|
2015-09-24 |
2022-01-19 |
F. Hoffmann-La Roche AG |
Bicyclic compounds as atx inhibitors
|
|
EP3353180B1
(en)
|
2015-09-24 |
2022-03-16 |
F. Hoffmann-La Roche AG |
Bicyclic compounds as atx inhibitors
|
|
CA3000988A1
(en)
|
2015-10-05 |
2017-04-13 |
The Trustees Of Columbia University In The City Of New York |
Activators of autophagic flux and phospholipase d and clearance of protein aggregates including tau and treatment of proteinopathies
|
|
GB201517523D0
(en)
|
2015-10-05 |
2015-11-18 |
Ostara Biomedical Ltd |
Methods and compositions for managing reproduction
|
|
WO2017063966A1
(en)
|
2015-10-13 |
2017-04-20 |
Bayer Pharma Aktiengesellschaft |
Substituted 2-(1h-pyrazol-1-yl)-benzothiazole compounds
|
|
EP3371188B1
(en)
|
2015-11-02 |
2019-10-23 |
Janssen Pharmaceutica NV |
[1,2,4]triazolo[1,5-a]pyrimidin-7-yl compound
|
|
BR112018011390B1
(pt)
*
|
2015-12-07 |
2024-01-09 |
Hinova Pharmaceuticals Inc |
Compostos de quinolina, método de preparação dos mesmos, e uso dos mesmos como fármaco inibidor de transportador de urato
|
|
WO2017106367A1
(en)
*
|
2015-12-15 |
2017-06-22 |
D.E. Shaw Research, Llc |
Method of treating neurodegenerative disorders by rescuing alpha-synuclein toxicity
|
|
CN107840826B
(zh)
*
|
2016-09-19 |
2021-07-09 |
西华大学 |
1h-吲唑类衍生物及其作为ido抑制剂的用途
|
|
WO2017133258A1
(zh)
*
|
2016-02-04 |
2017-08-10 |
西华大学 |
1h-吲唑类衍生物及其作为ido抑制剂的用途
|
|
CN107033087B
(zh)
*
|
2016-02-04 |
2020-09-04 |
西华大学 |
1h-吲唑-4-胺类化合物及其作为ido抑制剂的用途
|
|
MA44725A
(fr)
|
2016-04-22 |
2019-02-27 |
Incyte Corp |
Formulations d'un inhibiteur de lsd1
|
|
WO2017210545A1
(en)
|
2016-06-02 |
2017-12-07 |
Cadent Therapeutics, Inc. |
Potassium channel modulators
|
|
MA45189A
(fr)
|
2016-06-07 |
2019-04-10 |
Jacobio Pharmaceuticals Co Ltd |
Nouveaux dérivés hétérocycliques utiles en tant qu'inhibiteurs de shp2
|
|
AU2017281797A1
(en)
|
2016-06-24 |
2019-01-24 |
Infinity Pharmaceuticals, Inc. |
Combination therapies
|
|
KR20190026902A
(ko)
|
2016-07-14 |
2019-03-13 |
화이자 인코포레이티드 |
바닌-1 효소의 억제제로서의 신규 피리미딘 카르복스아미드
|
|
WO2018030762A1
(ko)
*
|
2016-08-09 |
2018-02-15 |
세종대학교산학협력단 |
Ampk 억제기능에 기반한 뇌졸중 치료용 약학적 조성물
|
|
US11084807B2
(en)
|
2016-08-18 |
2021-08-10 |
Vidac Pharama Ltd. |
Piperazine derivatives, pharmaceutical compositions and methods of use thereof
|
|
PE20190607A1
(es)
|
2016-09-02 |
2019-04-23 |
Ironwood Pharmaceuticals Inc |
Estimuladores de sgc
|
|
CN106432235B
(zh)
*
|
2016-10-19 |
2018-02-02 |
南通大学 |
靶向CDK和DNA的β‑咔啉衍生物及其制备方法和医药用途
|
|
CN110099898B
(zh)
|
2016-10-24 |
2023-07-25 |
优曼尼蒂治疗公司 |
化合物及其用途
|
|
MA46690A
(fr)
|
2016-11-02 |
2019-09-11 |
Janssen Pharmaceutica Nv |
Composés de [1,2,4]triazolo [1,5-a]pyrimidine en tant qu'inhibiteurs de pde2
|
|
KR20190070972A
(ko)
*
|
2016-11-02 |
2019-06-21 |
얀센 파마슈티카 엔.브이. |
Pde2 억제제로서의 [1,2,4]트리아졸로[1,5-a]피리미딘 유도체
|
|
BR112019008163A2
(pt)
|
2016-11-02 |
2019-07-09 |
Janssen Pharmaceutica Nv |
compostos de [1,2,4]triazolo[1,5-a]pirimidina como inibidores de pde2
|
|
WO2018089967A1
(en)
|
2016-11-14 |
2018-05-17 |
Virginia Commonwealth University |
Inhibitors of cancer invasion, attachment, and/or metastasis
|
|
WO2018094106A2
(en)
|
2016-11-16 |
2018-05-24 |
University Of South Florida |
ALLOSTERIC ANTAGONISTS OF GPRC6a AND THEIR USE IN MITIGATING PROTEINOPATHIES
|
|
WO2018129403A1
(en)
|
2017-01-06 |
2018-07-12 |
Yumanity Therapeutics |
Methods for the treatment of neurological disorders
|
|
EP3568133B1
(en)
*
|
2017-01-10 |
2023-12-13 |
ETH Zurich |
Cell-protective compounds and their use
|
|
AR110770A1
(es)
|
2017-01-23 |
2019-05-02 |
Cadent Therapeutics Inc |
Moduladores del canal de potasio
|
|
CN106748969B
(zh)
*
|
2017-01-23 |
2019-06-18 |
南阳师范学院 |
一种n-(4-苄基哌啶基)-阿魏酰胺化合物、制备方法及其用途
|
|
CN106831573B
(zh)
*
|
2017-01-23 |
2019-05-24 |
南阳师范学院 |
(n-1,2,3,4-四氢异喹啉基)-阿魏酰胺化合物、制备方法及其应用
|
|
CN110225908A
(zh)
|
2017-01-26 |
2019-09-10 |
小野药品工业株式会社 |
喹啉衍生物的乙磺酸盐
|
|
CA3052247A1
(en)
|
2017-02-01 |
2018-08-09 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
N1 -(4-(5-(cyclopropylmethyl)-1 -methyl-1 h-pyrazol-4-yl)pyridin-2-yl)cyclohexane-1,4-diamine derivatives and related compounds as ck1 and/or iraki inhibitors fortreating cancer
|
|
CN109793737B
(zh)
*
|
2017-03-01 |
2021-06-29 |
浙江大学 |
苯磺酰胺结构类型雄激素受体拮抗剂及其应用
|
|
EP3596060B1
(en)
|
2017-03-16 |
2023-09-20 |
F. Hoffmann-La Roche AG |
New bicyclic compounds as atx inhibitors
|
|
BR112019019017A2
(pt)
|
2017-03-16 |
2020-04-14 |
Hoffmann La Roche |
compostos heterocíclicos de utilidade como inibidores duplos de atx/ca
|
|
HUE045261T2
(hu)
|
2017-03-20 |
2019-12-30 |
Forma Therapeutics Inc |
Pirrolopirrol kompozíciók piruvát kináz (PKR) aktivátorokként
|
|
HRP20241239T1
(hr)
|
2017-03-23 |
2024-12-06 |
Jacobio Pharmaceuticals Co., Ltd. |
Novi heterociklički derivati korisni kao shp2 inhibitori
|
|
MX388196B
(es)
|
2017-04-26 |
2025-03-19 |
Basilea Pharm Int Ag |
Procesos para la preparacion de furazanobencimidazoles y formas cristalinas de estos.
|
|
EP3634406B1
(en)
*
|
2017-05-12 |
2023-09-06 |
Board of Trustees of The Southern Illinois University on behalf of Southern Illinois University Edwardsville |
3,4,5-trisubstituted-1,2,4-triazoles and 3,4,5-trisubstituted-3-thio-1,2,4-triazoles and uses thereof
|
|
AR111960A1
(es)
|
2017-05-26 |
2019-09-04 |
Incyte Corp |
Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
|
|
JOP20190282A1
(ar)
|
2017-06-09 |
2019-12-05 |
Novartis Ag |
مركبات وتركيبات لحث تكوّن الغضاريف
|
|
CA3067086A1
(en)
*
|
2017-06-14 |
2018-12-20 |
European Molecular Biology Laboratory |
Benzofuran amides and heteroaromatic analogues thereof for use in therapy
|
|
KR20200019228A
(ko)
|
2017-06-21 |
2020-02-21 |
미토키닌, 인크. |
신경퇴행성 및 미토콘드리아 질환의 치료를 위한 조성물 및 이를 사용하는 방법
|
|
GB201710851D0
(en)
*
|
2017-07-06 |
2017-08-23 |
Galápagos Nv |
Novel compounds and pharmaceutical compositions thereof for the treatment of fibrosis
|
|
EP3651766B1
(en)
|
2017-07-10 |
2024-09-11 |
Celgene Corporation |
4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-l-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-l-yl)-3-fluorobenzonitrile as antiproliferative compound
|
|
SG11202000230VA
(en)
|
2017-07-11 |
2020-02-27 |
Vertex Pharma |
Carboxamides as modulators of sodium channels
|
|
WO2019049965A1
(ja)
|
2017-09-11 |
2019-03-14 |
保土谷化学工業株式会社 |
ピリミジン環構造を有する化合物および有機エレクトロルミネッセンス素子
|
|
TWI846350B
(zh)
|
2017-09-15 |
2024-06-21 |
美商佛瑪治療公司 |
作為ＣＢＰ／ｐ３００抑制劑之四氫－咪唑並喹啉化合物
|
|
US11826363B2
(en)
|
2017-10-13 |
2023-11-28 |
Ono Pharmaceutical Co., Ltd. |
Therapeutic agent for solid cancers, which comprises Axl inhibitor as active ingredient
|
|
MX2020003993A
(es)
|
2017-10-19 |
2020-08-13 |
Teijin Pharma Ltd |
Derivados de bencimidazol y sus usos.
|
|
CA3083000A1
(en)
|
2017-10-24 |
2019-05-02 |
Yumanity Therapeutics, Inc. |
Compounds and uses thereof
|
|
EP3728201A1
(en)
*
|
2017-12-21 |
2020-10-28 |
Gliapharm SA |
Compositions and methods of treatment for neurological disorders comprising a dementia
|
|
SG11202004971YA
(en)
*
|
2017-12-21 |
2020-06-29 |
Gliapharm Sa |
Compositions and methods of treatment for neurological disorders comprising motor neuron diseases
|
|
MX2020008949A
(es)
|
2018-02-27 |
2021-01-08 |
Incyte Corp |
Imidazopirimidinas y triazolopirimidinas como inhibidores de a2a / a2b.
|
|
WO2019173437A1
(en)
*
|
2018-03-06 |
2019-09-12 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Positive allosteric modulators of dopamine 1 receptor and method of use thereof
|
|
EP3543231A1
(en)
*
|
2018-03-19 |
2019-09-25 |
ETH Zurich |
Compounds for treating cns- and neurodegenerative diseases
|
|
CA3094527A1
(en)
|
2018-03-23 |
2019-09-26 |
Yumanity Therapeutics, Inc. |
Compounds and uses thereof
|
|
CR20240498A
(es)
|
2018-05-04 |
2025-01-08 |
Incyte Corp |
FORMAS SÓLIDAS DE UN INHIBIDOR DE FGFR Y PROCESOS PARA PREPARARLAS (Divisional EXP. 2020-0590)
|
|
BR112020022373A2
(pt)
|
2018-05-04 |
2021-02-02 |
Incyte Corporation |
sais de um inibidor de fgfr
|
|
TWI815887B
(zh)
*
|
2018-05-15 |
2023-09-21 |
美商愛彼特生物製藥股份有限公司 |
經取代的2,2'-雙嘧啶基化合物、其類似物及其使用方法
|
|
CA3100731A1
(en)
|
2018-05-18 |
2019-11-21 |
Incyte Corporation |
Fused pyrimidine derivatives as a2a / a2b inhibitors
|
|
MX2020012826A
(es)
|
2018-06-01 |
2021-03-09 |
Incyte Corp |
Regimen de dosificacion para el tratamiento de trastornos relacionados con fosfatidilinositol 3-cinasas (pi3k).
|
|
GB201810092D0
(en)
|
2018-06-20 |
2018-08-08 |
Ctxt Pty Ltd |
Compounds
|
|
GB201810581D0
(en)
|
2018-06-28 |
2018-08-15 |
Ctxt Pty Ltd |
Compounds
|
|
KR102805503B1
(ko)
|
2018-06-29 |
2025-05-09 |
포르마 세라퓨틱스 인크. |
Creb 결합 단백질(cbp)의 저해
|
|
SG11202013216RA
(en)
|
2018-07-05 |
2021-01-28 |
Incyte Corp |
Fused pyrazine derivatives as a2a / a2b inhibitors
|
|
IL307972A
(en)
*
|
2018-08-06 |
2023-12-01 |
Univ Leland Stanford Junior |
2-Arylbenzimidazoles as PPARCG1A agonists for the treatment of neurodegenerative diseases
|
|
KR102817790B1
(ko)
|
2018-08-29 |
2025-06-05 |
케모센트릭스, 인크. |
C-c 케모카인 수용체 4(ccr4) 길항제 및 하나 이상의 면역 체크포인트 억제제를 사용한 병용 요법
|
|
WO2020047198A1
(en)
|
2018-08-31 |
2020-03-05 |
Incyte Corporation |
Salts of an lsd1 inhibitor and processes for preparing the same
|
|
US11278527B2
(en)
|
2018-09-04 |
2022-03-22 |
Brown University |
Compositions and methods for the modulation of the corticotropin releasing factor binding protein and the treatment of alcohol use disorder
|
|
JP7646132B2
(ja)
*
|
2018-09-09 |
2025-03-17 |
カナートファーマ アーゲー |
血管疾患の治療におけるカゼインキナーゼ１阻害剤の使用
|
|
TWI827677B
(zh)
|
2018-09-18 |
2024-01-01 |
美商尼坎醫療公司 |
作為src同源-2磷酸酶抑制劑之稠合三環衍生物
|
|
US12122778B2
(en)
|
2018-09-19 |
2024-10-22 |
Novo Nordisk Health Care Ag |
Activating pyruvate kinase R
|
|
CN113166060B
(zh)
|
2018-09-19 |
2024-01-09 |
诺沃挪第克健康护理股份公司 |
用丙酮酸激酶激活化合物治疗镰状细胞病
|
|
US20210393623A1
(en)
|
2018-09-26 |
2021-12-23 |
Jacobio Pharmaceuticals Co., Ltd. |
Novel Heterocyclic Derivatives Useful as SHP2 Inhibitors
|
|
KR20210080446A
(ko)
|
2018-10-22 |
2021-06-30 |
카덴트 테라퓨틱스, 인크. |
칼륨 채널 조절제의 결정 형태
|
|
EP3870287B1
(en)
*
|
2018-10-23 |
2026-01-14 |
Daiichi Sankyo Company, Limited |
Biaryl derivative
|
|
WO2020093098A1
(en)
|
2018-11-07 |
2020-05-14 |
The University Of Melbourne |
Novel compounds for the treatment of respiratory diseases
|
|
CN109503563B
(zh)
*
|
2018-12-10 |
2020-05-12 |
济南大学 |
多功能乙酰胆碱酯酶抑制剂及其应用
|
|
KR102128509B1
(ko)
*
|
2018-12-19 |
2020-07-01 |
한국과학기술연구원 |
말단 아민기에 아릴 또는 헤테로아릴기가 치환된 신규한 히드라존 유도체 및 이의 용도
|
|
AU2020204991A1
(en)
*
|
2019-01-04 |
2021-07-22 |
Bellbrook Labs, Llc |
Inhibitors of cGAS activity as therapeutic agents
|
|
WO2020146612A1
(en)
|
2019-01-10 |
2020-07-16 |
Vertex Pharmaceuticals Incorporated |
Esters and carbamates as modulators of sodium channels
|
|
WO2020146682A1
(en)
|
2019-01-10 |
2020-07-16 |
Vertex Pharmaceuticals Incorporated |
Carboxamides as modulators of sodium channels
|
|
KR20220007845A
(ko)
|
2019-01-24 |
2022-01-19 |
유마니티 테라퓨틱스, 인크. |
화합물 및 이의 용도
|
|
TWI829857B
(zh)
|
2019-01-29 |
2024-01-21 |
美商英塞特公司 |
作為a2a / a2b抑制劑之吡唑并吡啶及三唑并吡啶
|
|
WO2020185532A1
(en)
|
2019-03-08 |
2020-09-17 |
Incyte Corporation |
Methods of treating cancer with an fgfr inhibitor
|
|
WO2020190791A1
(en)
|
2019-03-15 |
2020-09-24 |
Forma Therapeutics, Inc. |
Inhibiting cyclic amp-responsive element-binding protein (creb)
|
|
US11505548B2
(en)
*
|
2019-04-26 |
2022-11-22 |
Celgene Corporation |
Heterocyclic compounds and their use for treatment of helminthic infections and diseases
|
|
UY38687A
(es)
|
2019-05-17 |
2023-05-15 |
Novartis Ag |
Inhibidores del inflamasoma nlrp3, composiciones, combinaciones de los mismos y métodos para su uso
|
|
PL4299135T3
(pl)
|
2019-06-18 |
2025-11-12 |
Pfizer Inc. |
Pochodne benzizoksazolosulfonamidu
|
|
US11591329B2
(en)
|
2019-07-09 |
2023-02-28 |
Incyte Corporation |
Bicyclic heterocycles as FGFR inhibitors
|
|
WO2021021986A1
(en)
|
2019-07-31 |
2021-02-04 |
Ribon Therapeutics, Inc. |
Heterobicyclic amides as inhibitors of cd38
|
|
RU2746423C2
(ru)
*
|
2019-09-02 |
2021-04-13 |
Общество с ограниченной ответственностью "Научно-исследовательский институт ХимРар" (ООО "НИИ ХимРар") |
Ингибитор вируса гепатита В (ВГВ)
|
|
ES3042390T3
(en)
|
2019-09-19 |
2025-11-20 |
Novo Nordisk Healthcare Ag |
Pyruvate kinase r (pkr) activating compositions
|
|
WO2021067374A1
(en)
|
2019-10-01 |
2021-04-08 |
Incyte Corporation |
Bicyclic heterocycles as fgfr inhibitors
|
|
JOP20220083A1
(ar)
|
2019-10-14 |
2023-01-30 |
Incyte Corp |
حلقات غير متجانسة ثنائية الحلقة كمثبطات لـ fgfr
|
|
US11566028B2
(en)
|
2019-10-16 |
2023-01-31 |
Incyte Corporation |
Bicyclic heterocycles as FGFR inhibitors
|
|
EA202192047A1
(ru)
|
2019-11-13 |
2021-12-08 |
Юманити Терапьютикс, Инк. |
Соединения и их применение
|
|
US12343335B2
(en)
|
2019-11-14 |
2025-07-01 |
Zincure Corp. |
Pharmaceutical composition for treating multiple sclerosis on basis of AMPK inhibitory function and zinc homeostasis control function
|
|
PE20221504A1
(es)
|
2019-12-04 |
2022-09-30 |
Incyte Corp |
Derivados de un inhibidor de fgfr
|
|
EP4069696A1
(en)
|
2019-12-04 |
2022-10-12 |
Incyte Corporation |
Tricyclic heterocycles as fgfr inhibitors
|
|
DK4069691T3
(da)
|
2019-12-06 |
2024-10-28 |
Vertex Pharma |
Substituerede tetrahydrofuraner som modulatorer af natriumkanaler
|
|
US12012409B2
(en)
|
2020-01-15 |
2024-06-18 |
Incyte Corporation |
Bicyclic heterocycles as FGFR inhibitors
|
|
AR122711A1
(es)
*
|
2020-06-25 |
2022-09-28 |
Alchemedicine Inc |
COMPUESTO HETEROCÍCLICO COMO INHIBIDOR DE CASEÍNA QUINASA 1d Y/O QUINASA 5 TIPO RECEPTOR DE ACTIVINA
|
|
WO2022035805A1
(en)
*
|
2020-08-10 |
2022-02-17 |
Dana-Farber Cancer Institute, Inc. |
Substituted 1,2,4-oxadiazoles as small molecule inhibitors of ubiquitin-specific protease 28
|
|
US20230339900A1
(en)
*
|
2020-09-17 |
2023-10-26 |
Janssen Pharmaceutica Nv |
Casein kinase 1 delta modulators
|
|
US11795168B2
(en)
|
2020-09-23 |
2023-10-24 |
Forma Therapeutics, Inc. |
Inhibiting cyclic amp-responsive element-binding protein (CREB) binding protein (CBP)
|
|
US11801243B2
(en)
|
2020-09-23 |
2023-10-31 |
Forma Therapeutics, Inc. |
Bromodomain inhibitors for androgen receptor-driven cancers
|
|
GB202101734D0
(en)
*
|
2021-02-08 |
2021-03-24 |
Cerevance Inc |
Novel Compounds
|
|
KR20230159421A
(ko)
|
2021-02-19 |
2023-11-21 |
수도 바이오사이언시즈 리미티드 |
Tyk2 억제제 및 이의 용도
|
|
WO2022175747A1
(en)
|
2021-02-19 |
2022-08-25 |
Sudo Biosciences Limited |
Tyk2 inhibitors and uses thereof
|
|
US12128035B2
(en)
|
2021-03-19 |
2024-10-29 |
Novo Nordisk Health Care Ag |
Activating pyruvate kinase R
|
|
EP4323405A1
(en)
|
2021-04-12 |
2024-02-21 |
Incyte Corporation |
Combination therapy comprising an fgfr inhibitor and a nectin-4 targeting agent
|
|
WO2022222963A1
(zh)
*
|
2021-04-21 |
2022-10-27 |
长春金赛药业有限责任公司 |
含咪唑稠环类衍生物、其制备方法及其在医药上的应用
|
|
US11827627B2
(en)
|
2021-06-04 |
2023-11-28 |
Vertex Pharmaceuticals Incorporated |
N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels
|
|
JP2024522188A
(ja)
|
2021-06-09 |
2024-06-11 |
インサイト・コーポレイション |
Ｆｇｆｒ阻害剤としての三環式ヘテロ環
|
|
EP4352059A1
(en)
|
2021-06-09 |
2024-04-17 |
Incyte Corporation |
Tricyclic heterocycles as fgfr inhibitors
|
|
WO2023064133A1
(en)
*
|
2021-10-15 |
2023-04-20 |
Lomond Therapeutics, Inc. |
SUBSTITUTED 1H-PYRAZOLO [4,3-c] QUINOLINES, METHODS OF PREPARATION, AND USE THEREOF
|
|
WO2023205463A1
(en)
|
2022-04-22 |
2023-10-26 |
Vertex Pharmaceuticals Incorporated |
Heteroaryl compounds for the treatment of pain
|
|
CN115466211B
(zh)
*
|
2022-06-09 |
2024-02-23 |
中国人民解放军空军军医大学 |
一种n-苯基喹啉-4-胺类化合物及其应用
|
|
WO2024012554A1
(zh)
*
|
2022-07-14 |
2024-01-18 |
上海日馨医药科技股份有限公司 |
Tpk激动剂及使用其治疗神经退行性疾病的方法
|
|
UY40374A
(es)
|
2022-08-03 |
2024-02-15 |
Novartis Ag |
Inhibidores de inflamasoma nlrp3
|
|
IL319655A
(en)
*
|
2022-10-19 |
2025-05-01 |
Changchun Genescience Pharmaceutical Co Ltd |
Crystal form of NK3R antagonist, method of preparation thereof and use thereof
|
|
CN120917015A
(zh)
*
|
2023-01-20 |
2025-11-07 |
元启(苏州)生物制药有限公司 |
Srpk1抑制剂和使用方法
|
|
AR131690A1
(es)
*
|
2023-01-30 |
2025-04-23 |
Eurofarma Laboratorios S A |
COMPUESTOS FENÓLICOS BLOQUEADORES DE Nav 1.7 Y/O Nav 1.8, SUS PROCESOS DE OBTENCIÓN, SUS COMPOSICIONES, SUS USOS, LOS MÉTODOS DE TRATAMIENTO DE LOS MISMOS Y LOS KITS
|
|
EP4660182A1
(en)
*
|
2023-01-30 |
2025-12-10 |
Eurofarma Laboratórios S.A. |
Nav1.7- and/or nav1.8-inhibiting aryl pyridine compounds, processes for the preparation thereof, compositions, uses, methods for treatment using same, and kits
|
|
CN118666857B
(zh)
*
|
2024-06-26 |
2025-02-25 |
江西农业大学 |
一种喹啉类化合物及其在农用杀菌剂中的应用
|
|
CN119060061B
(zh)
*
|
2024-08-26 |
2025-09-16 |
浙江师范大学 |
一类苯并嘧啶硫醚类化合物作为sting蛋白小分子抑制剂的应用
|